Why the study?
Does a 2-5A-antisense chimera (NIH351) inhibit RSV replication in cell culture models compared to ribavirin?
Population
Cell culture models of respiratory syncytial virus (RSV) infection (strains A and B subgroups)
Comparison
2-5A-antisense chimera targeting a consensus… vs Ribavirin, scrambled nucleotide sequence…
Design
Preclinical
Authors
Loading...
May advance 2-5A-antisense chimeras for RSV; leaves open translation beyond cell culture.
Does a 2-5A-antisense chimera (NIH351) inhibit RSV replication in cell culture models compared to ribavirin?
A novel 2-5A-antisense chimera (NIH351) demonstrates highly potent, specific, and targeted inhibition of RSV replication in vitro, significantly outperforming ribavirin.
Player et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: